期刊文献+
共找到100篇文章
< 1 2 5 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
INTRODUCTIONHepatolenticulardegeneration(HLD)isanautosomalrecesivedisorderthatcauseschangesinthebasalganglia... INTRODUCTIONHepatolenticulardegeneration(HLD)isanautosomalrecesivedisorderthatcauseschangesinthebasalgangliaandliverthatrespe... 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Thrapeutic equivalence in the treatment of hypertension:Can lercanidipine and nifedipine GITS be considered to be interchangeable? 被引量:1
7
作者 Henry L Elliott Peter A Meredith 《World Journal of Cardiology》 CAS 2014年第6期507-513,共7页
AIM: To undertake a review of the evidence that nifedipine GITS and lercanidipine are therapeutically equivalent in the management of essential hypertension.METHODS: A systematic review of the published literature was... AIM: To undertake a review of the evidence that nifedipine GITS and lercanidipine are therapeutically equivalent in the management of essential hypertension.METHODS: A systematic review of the published literature was prompted by the findings of two meta-analyses which indicated that there was a lower incidence of peripheral(ankle) oedema with lercanidipine. However,neither meta-analysis gave detailed attention to comparative antihypertensive efficacy or cardiovascular protection. Accordingly,a systematic,detailed and critical review was undertaken of individual published papers. The review started with those studies incorporated into the 2 meta-analyses and then all other salient and directly relevant papers identified through the following search criteria: all randomized controlled trials in which the therapeutic profile and antihypertensive effects of lercanidipine were directly compared with those of nifedipine GITS(in hypertensive patients). The searchstrategy was focused on the reports of clinical trials of lercanidipine vs nifedipine GITS,which were identified through a systematic search of PubMed(from 1966 to October 2012),Embase(from 1980 to October 2012) and the Cochrane library(from 1 October 2008 to end October 2013). The search combined terms related to lercanidipine vs nifedipine GITS(including MeSH search using calcium antagonists,calcium channel blockers and dihydropyridines).RESULTS: With regard to blood pressure(BP) control and the consistency of BP control throughout 24-h,there is limited published evidence. However,two studies using 24 h ambulatory blood pressure monitoring clearly identified the dose-dependency of BP lowering with lercanidipine and its variably sustained 24-h efficacy. In contrast,there is evidence of a consistent antihypertensive effect throughout 24 h with nifedipine GITS. The incidence of the most common "side effect",i.e.,peripheral(ankle) oedema can be estimated as follows. For every 100 patients treated with lercanidipine,2.5 will report oedema compared to 6 patients treated with nifedipine GITS. However,98 or 99 patients will continue treatment with nifedipine GITS,compared with 99.5 patients on lercanidipine. Finally,with regard to outcome studies of cardiovascular(CV) morbidity and mortality,there is definitive outcome evidence for nifedipine GITS but there is no evidence that treatment with lercanidipine leads to reductions in CV morbidity and mortality.CONCLUSION: There is no evidence in terms of longterm BP control and CV protection to justify the contention that lercanidipine is therapeutically equivalent to nifedipine GITS. 展开更多
关键词 nifedipine GITS LERCANIDIPINE 治疗学的等价
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
8
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
硝苯地平联合硫酸镁治疗妊娠期高血压患者的疗效分析
9
作者 唐安萍 王丽 《中国医药指南》 2024年第17期95-98,共4页
目的分析硝苯地平联合硫酸镁治疗妊娠期高血压(PIH)患者的疗效。方法选取贵州省黔西南州人民医院产科2022年1月至2023年12月收治的100例PIH患者,根据不同疗法纳入对照组(50例)与观察组(50例),对照组予以硝苯地平治疗,观察组予以硝苯地... 目的分析硝苯地平联合硫酸镁治疗妊娠期高血压(PIH)患者的疗效。方法选取贵州省黔西南州人民医院产科2022年1月至2023年12月收治的100例PIH患者,根据不同疗法纳入对照组(50例)与观察组(50例),对照组予以硝苯地平治疗,观察组予以硝苯地平联合硫酸镁治疗,对比两组的血压水平(SBP、DBP)、尿肌酐与尿蛋白水平、心率(产妇、胎儿)、临床疗效、不良反应(恶心呕吐、头晕、皮肤瘙痒、消化道出血)、不良妊娠结局(宫颈裂伤、过度宫缩、急产、产后出血、新生儿窒息)。结果两组治疗后的SBP、DBP均降低,且观察组低于对照组,P<0.05;两组治疗后的尿肌酐与尿蛋白均降低,且观察组低于对照组,P<0.05;两组治疗后产妇、胎儿的心率均降低,且观察组低于对照组,P<0.05;观察组总有效率高于对照组,P<0.05;两组不良反应发生率相近,P>0.05;观察组不良妊娠结局发生率低于对照组,P<0.05。结论硝苯地平联合硫酸镁治疗PIH患者的疗效较好,可有效控制患者血压,改善尿肌酐与尿蛋白水平,降低母婴心率,改善妊娠结局,且不良反应少。 展开更多
关键词 妊娠期高血压 硝苯地平 硫酸镁 血压 妊娠结局
下载PDF
硝苯地平联合硫酸镁治疗妊娠高血压疾病安全性的研究
10
作者 和光宇 李良 《中外医疗》 2024年第11期129-132,共4页
目的探究硝苯地平联合硫酸镁治疗妊娠高血压患者的作用。方法随机选取2021年8月—2023年8月济宁市兖州区人民医院收治的70例妊娠高血压患者作为研究对象,采用盲摸双色球法分为联合组、单一组,各35例。单一组给予硫酸镁治疗,联合组在单... 目的探究硝苯地平联合硫酸镁治疗妊娠高血压患者的作用。方法随机选取2021年8月—2023年8月济宁市兖州区人民医院收治的70例妊娠高血压患者作为研究对象,采用盲摸双色球法分为联合组、单一组,各35例。单一组给予硫酸镁治疗,联合组在单一组基础上加用硝苯地平治疗。比较两组治疗效果、血压控制情况、相关临床指标、不良反应发生情况、妊娠结局情况。结果联合组治疗总有效率高于单一组,联合组血压水平低于单一组,差异有统计学意义(P均<0.05)。联合组内皮素、一氧化氮、肿瘤坏死因子-α、白细胞介素-6及超敏C反应蛋白水平均优于单一组,差异有统计学意义(P均<0.05)。两组不良反应总发生率比较,差异无统计学意义(χ^(2)=4.629,P>0.05)。联合组不良妊娠结局率低于单一组(8.58%vs28.57%),差异有统计学意义(χ^(2)=4.629,P<0.05)。结论硝苯地平联合硫酸镁治疗妊娠期高血压患者能够提高治疗效果,控制血压发展,改善相关临床指标,减少不良反应发生,优化妊娠结局。 展开更多
关键词 硝苯地平 硫酸镁 妊娠高血压 治疗效果 不良反应发生情况 妊娠结局情况
下载PDF
硝苯地平联合拉贝洛尔治疗妊娠期高血压疾病的效果分析
11
作者 王媛媛 《实用妇科内分泌电子杂志》 2024年第4期89-91,共3页
目的探讨硝苯地平联合拉贝洛尔治疗妊娠期高血压疾病的临床疗效。方法选取104例妊娠期高血压疾病患者为研究对象,采用随机数字表法分为对照组和研究组,每组52例。对照组使用硝苯地平治疗,研究组使用硝苯地平联合拉贝洛尔治疗,比较两组... 目的探讨硝苯地平联合拉贝洛尔治疗妊娠期高血压疾病的临床疗效。方法选取104例妊娠期高血压疾病患者为研究对象,采用随机数字表法分为对照组和研究组,每组52例。对照组使用硝苯地平治疗,研究组使用硝苯地平联合拉贝洛尔治疗,比较两组血压控制情况及孕妇健康状态。结果治疗前,两组收缩压、舒张压水平比较差异均无统计学意义(P>0.05);治疗后,研究组收缩压、舒张压水平均优于对照组(P<0.05);治疗前,两组身体疲劳、情绪状态、血液检测评分比较,差异均无统计学意义(P>0.05);治疗后研究组身体疲劳、情绪状态、血液检测评分均高于对照组(P<0.05)。结论妊娠期高血压疾病采用硝苯地平联合拉贝洛尔治疗效果较好,可控制血压水平,改善孕妇健康状态,值得临床推广与应用。 展开更多
关键词 妊娠期高血压疾病 硝苯地平 拉贝洛尔 治疗效果
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
12
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
13
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
分析硫酸镁与硝苯地平联合治疗妊娠期高血压综合征对其脐血流指数的影响 被引量:1
14
作者 陈麟 姚晓芳 张红梅 《系统医学》 2023年第3期159-162,共4页
目的探讨对妊娠期高血压综合征患者采用硫酸镁+硝苯地平药物联合治疗后对其脐血流指数等产生的影响。方法选取2019年1月—2021年12月常熟市第二人民医院收治的101例妊娠期高血压综合征患者进行研究。随机分为常规组(50例,采用硫酸镁药... 目的探讨对妊娠期高血压综合征患者采用硫酸镁+硝苯地平药物联合治疗后对其脐血流指数等产生的影响。方法选取2019年1月—2021年12月常熟市第二人民医院收治的101例妊娠期高血压综合征患者进行研究。随机分为常规组(50例,采用硫酸镁药物治疗)和研究组(51例,采用硫酸镁+硝苯地平药物治疗)。比较两组患者治疗总有效率、血压指标[舒张压(DBP)、收缩压(SBP)]、血压达标时间、24 h尿蛋白定量、红细胞压积(HCT)、血浆黏度(PV)以及脐血流指数(S/D)。结果研究组治疗总有效率(96.08%)较常规组(78.00%)高,差异有统计学意义(χ^(2)=7.358,P<0.05)。治疗前,研究组DBP(102.19±6.35)mmHg、SBP(172.31±15.59)mmHg与常规组对比,差异无统计学意义(P>0.05);治疗后,研究组DBP(83.52±4.33)mmHg、SBP(130.22±11.83)mmHg较常规组降低,差异有统计学意义(P<0.05)。研究组血压达标时间(7.59±1.99)d较常规组缩短,差异有统计学意义(P<0.05);研究组24 h尿蛋白定量(1.35±0.29)g较常规组降低,差异有统计学意义(P<0.05)。治疗前,研究组HCT(45.29±2.53)%、PV(1.99±2.53)mp·s以及S/D(2.69±0.59)与常规组对比,差异无统计学意义(P>0.05);治疗后,研究组HCT(25.33±3.96)%、PV(1.26±0.53)mp·s以及S/D(2.31±0.25)较常规组降低,差异有统计学意义(P<0.05)。结论硫酸镁+硝苯地平药物联合应用,可显著提高患者治疗效果,降低血压水平,缩短血压达标时间,此外可显著改善24 h尿蛋白定量、HCT、PV以及S/D,促进妊娠期高血压综合征患者获得良好预后。 展开更多
关键词 硫酸镁 硝苯地平 妊娠期高血压综合征 脐血流指数 治疗效果
下载PDF
硝苯地平联合硫酸镁治疗妊娠期高血压的临床效果 被引量:2
15
作者 孙迪 《妇儿健康导刊》 2023年第4期112-114,共3页
目的分析硝苯地平联合硫酸镁治疗妊娠期高血压的临床效果。方法选取2020年7月至2022年8月淄博莲池妇婴医院收治的70例妊娠期高血压患者作为研究对象,按随机数字表法分为对照组和研究组,每组35例。对照组采用硫酸镁治疗,研究组采用硝苯... 目的分析硝苯地平联合硫酸镁治疗妊娠期高血压的临床效果。方法选取2020年7月至2022年8月淄博莲池妇婴医院收治的70例妊娠期高血压患者作为研究对象,按随机数字表法分为对照组和研究组,每组35例。对照组采用硫酸镁治疗,研究组采用硝苯地平联合硫酸镁治疗。比较两组治疗效果、不良反应、血压水平及不良妊娠结局。结果研究组治疗总有效率高于对照组,不良反应发生率低于对照组;治疗后两组的舒张压、收缩压水平均低于本组治疗前,且治疗后研究组的舒张压、收缩压水平低于对照组;研究组不良妊娠结局总发生率低于对照组。差异均有统计学意义(P<0.05)。结论硝苯地平联合硫酸镁对于稳定妊娠期高血压患者的血压水平、保障母胎安全有积极效果,治疗效果理想,可减少不良妊娠结局的发生。 展开更多
关键词 妊娠期高血压 硝苯地平 硫酸镁 治疗效果 安全性
下载PDF
The role of drug utilization evaluation in medical sciences
16
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
硝苯地平联合硫酸镁在妊娠期高血压疾病患者中的应用
17
作者 宗丹丹 《实用妇科内分泌电子杂志》 2023年第10期70-72,共3页
目的探讨硝苯地平联合硫酸镁在妊娠期高血压疾病患者治疗中的应用效果。方法选取80例妊娠期高血压疾病患者为研究对象,按不同就诊时间分为对照组和试验组,每组40例。对照组给予硫酸镁治疗,试验组在对照组基础上给予硝苯地平口服治疗,比... 目的探讨硝苯地平联合硫酸镁在妊娠期高血压疾病患者治疗中的应用效果。方法选取80例妊娠期高血压疾病患者为研究对象,按不同就诊时间分为对照组和试验组,每组40例。对照组给予硫酸镁治疗,试验组在对照组基础上给予硝苯地平口服治疗,比较两组治疗后生活质量、血压水平、治疗有效率和不良反应发生率。结果治疗后,试验组血压水平优于对照组(P<0.05);试验组生活质量评分高于对照组(P<0.05);试验组治疗总有效率高于对照组(P<0.05);试验组不良反应总发生率低于对照组(P<0.05)。结论硝苯地平联合硫酸镁治疗妊娠期高血压疾病患者效果较好,可以快速稳定患者血压水平,提高其生活质量,并促进患者康复,值得临床推广与应用。 展开更多
关键词 妊娠期高血压疾病 硝苯地平 硫酸镁 治疗效果
下载PDF
硫酸镁联合硝苯地平治疗妊娠期高血压疾病的效果
18
作者 马志娟 《实用妇科内分泌电子杂志》 2023年第12期75-77,共3页
目的探讨硫酸镁联合硝苯地平治疗妊娠期高血压疾病的效果。方法选取本院收治的70例妊娠期高血压疾病患者为研究对象,根据电脑随机抽样方法分为两组,各35例。常规组给予硫酸镁治疗,研究组给予硫酸镁联合硝苯地平治疗,比较两组的血压情况... 目的探讨硫酸镁联合硝苯地平治疗妊娠期高血压疾病的效果。方法选取本院收治的70例妊娠期高血压疾病患者为研究对象,根据电脑随机抽样方法分为两组,各35例。常规组给予硫酸镁治疗,研究组给予硫酸镁联合硝苯地平治疗,比较两组的血压情况、治疗效果、并发症发生情况。结果治疗后,研究组的脐动脉阻力指数、红细胞比容、血液粘稠度、收缩压、舒张压均低于常规组(P<0.05);研究组治疗总有效率为97.14%,显著高于常规组的82.86%(P<0.05);研究组并发症发生率为2.86%,显著低于常规组的17.14%(P<0.05)。结论硫酸镁联合硝苯地平治疗妊娠期高血压疾病效果显著,能改善患者的血压水平,且并发症少,值得临床推广应用。 展开更多
关键词 硫酸镁 硝苯地平 妊娠期高血压疾病 治疗效果 并发症
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
19
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
硝苯地平和依那普利对高血压患者血压及肾功能影响 被引量:1
20
作者 张玲 文俐 +1 位作者 雷建蓉 邓建川 《重庆医学》 CAS CSCD 1999年第5期321-323,共3页
目的:采用前瞻性、随机对照设计、观察并比较依那普利和硝苯地平控释片对原发性高血压患者的降压效果及对肾功能的影响。方法:41例 Ⅰ、Ⅱ期原发性高血压患者停用一切降压药 5天后,进行24小时无创性动态血压监测和血清肌酐检测... 目的:采用前瞻性、随机对照设计、观察并比较依那普利和硝苯地平控释片对原发性高血压患者的降压效果及对肾功能的影响。方法:41例 Ⅰ、Ⅱ期原发性高血压患者停用一切降压药 5天后,进行24小时无创性动态血压监测和血清肌酐检测,依次随机分为A、B两组。A组口服硝苯地平控释片30mg/d;B组口服依那普利10mg/d。4周后复查动态血压监测及血清肌酐水平,比较治疗前后各项指标的变化。结果:两组患者的24小时及白昼、夜间平均收缩压(SBP),平均舒张压(DBP)均有下降,在降压的同时有 72. 7%的患者恢复了血压的昼夜节律;内生肌酐清除率( Ccr)有所增加( P< 0. 01; P< 0. 05)。 A组 Ccr的改善软 B组更为明显( P< 0. 05)。结论:两种药物对 Ⅰ、 Ⅱ期原发性高血压患者均有良好的降压效果和改善肾功能的作用,对于后一作用尤以硝苯地平控释片更显著。 展开更多
关键词 硝苯地平 依那普利 高血压 药物疗法 肾功能
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部